nature reviews cancer 175 271-285.stringer a. m. gibson r. j. logan r. m. bowen j. m. yeoh a. s.  keefe d. m. 2008. faecal microflora and b-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats.

however thus far only about 40 xenobiotic drugs have been investigated to study the impact of the gut microbiome on drug metabolism .since the biogeography of gut microbiome is dramatically changed by the diet medication or environmental factors   drug metabolism by the host cells as well as the gut microbiome should be simultaneously contemplated for validating the drug candidates during the drug development process.

bmc oral health 141 80.sadabad m. s. von martels j. z. khan m. t. et al.

scientific reports 5 17906.khan m. t. duncan s. h. stams a. j. van dijl j. m. flint h. j.  harmsen h. j.

environmental microbiology 1110 2574-2584.lopez-siles m. duncan s. h. garcia-gil l. j.  martinez- medina m. 2017. faecalibacterium prausnitzii frommicrobiology to diagnostics and prognostics.

journal of infectious diseases 1625 1096-1106.krishnan m. penrose h. m. shah n. n. marchelletta r. r.  mccole d. f. 2016. vsl 3 probiotic stimulates t-cell protein tyrosine phosphatase-mediated recovery of ifn-g-induced intes- tinal epithelial barrier defects.

infection and immunity 601 237-248.kazi m. paramita s. sheikh i. chakraborty s. 2014. zinc recovers altered intestinial ion-transport and barrier function caused by shigella infection in t84 cells 902.9. the faseb journal 281 supplement 902.909.eckmann l. kagnoff m.  fierer j.

infection and immunity 6111 4569-4574.roselli m. finamore a. britti m. s. et al.

applied and environmental microbiology 784 1140-1147.hidalgo i. j. raub t. j.  borchardt r. t. 1989. characterization of the human colon carcinoma cell line caco-as a model system for intestinal epithelial permeability.gastroenterology 963 736-749.roselli m. finamore a. britti m. s.  mengheri e. 2006. probiotic bacteria bifidobacterium animalis mb5 and lactobacillus rhamnosus gg protect intestinal caco-2 cells from the inflammation-associated response induced by enterotoxigenic escherichia coli k88.

gut 471 79-87.rescigno m. urbano m. valzasina b. et al.

biomacromolecules 1512 4495-4508.kelm j. m. timmins n. e. brown c. j. fussenegger m.  nielsen l. k. 2003. method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types.

gastroenterology 1415 1762-1772.mccracken k. w. cata e. m. crawford c. m. et al.

elife 4 e05098.mondrinos m. j. jones p. l. finck c. m.  lelkes p. i.

nature 5267574 564-568.lancaster m. a. renner m. martin c.-a.

infection and immunity 6411 4751-4760.carol m. borruel n. antolin m. et al.

